Search
Now showing items 11-20 of 48
Article
O panorama da vigilância de eventos adversos pós-vacinação ao fim da década de 2010: importância, ferramentas e desafios
| Date Issued:
2020 | Copyright:
open access
Papers presented at events
Estudo fase I, de segurança e imunogenicidade, da vacina dupla viral, para sarampo e rubéola, em adultos jovens
| Date Issued:
2018 | Copyright:
open access
Papers presented at events
Duração da imunidade após uma dose da vacina de febre amarela em crianças vacinadas nos dois primeiros anos de vida
| Date Issued:
2018 | Copyright:
open access
Papers presented at events
Estudo comparativo da imunogenicidade da vacina tríplice viral (sarampo, caxumba e rubéola) nas apresentações monodose e multidose, em lactentes
| Date Issued:
2018 | Copyright:
open access
Papers presented at events
Adverse event profile of ChAdOx1 nCoV-19 vaccine (AZD1222) in Brazil: Comparison between Bio-Manguinhos/Fiocruz post-marketing surveillance database and clinical trials
| Date Issued:
2022 | Copyright:
open access
Papers presented at events
Pharmacovigilance Committee for COVID-19 vaccine (ChAdOx1-S [recombinant]) and its contribution for an effective benefit-risk assessment
| Date Issued:
2022 | Copyright:
open access
Papers presented at events
Situational strategic planning of the pharmacovigilance of Covid-19 vaccine (ChAdOx1-S [recombinant]) at Bio-Manguinhos/Fiocruz
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Pharmacovigilance of biotechnological therapies: how Bio-Manguinhos has been preparing itself for the challenges that have arisen?
| Date Issued:
2013 | Copyright:
open access
Papers presented at events
Current challenge in pharmacovigilance at Bio-Manguinhos/Fiocruz: detection of drugrelated [sic] problems in social media
| Date Issued:
2016 | Copyright:
open access